In a new study from consulting firm Numerof & Associates and the Jefferson College of Population Health, more than half of healthcare providers said that they get no more than 20 percent of revenue from risk-based contracts.
Top stories this week included the remarks of a Biogen VP on Google, and Alphabet’s earnings report this week – particularly as it could relate to healthcare.
Peach does not have a newsfeed, so, in theory, it’s less of a time suck than Facebook or Twitter. But is it suitable for healthcare?
Two year-old startup Rise finds exit in the form of a $20 million acquisition by One Medical.
In a move that will clearly up its focus on RNA diagnostics, St. Louis-based Cofactor Genomics has acquired San Francisco’s Narus Biotechnologies.
“The electronic medical record is a disaster,” SAP CEO Bill McDermott said in a meeting with financial analysts this week. He knows from personal experience.
scPharmaceuticals has raised $3.6 million in what looks to be a bridge financing round for its drug/device combo that could replace IV use in treating heart failure and infections.
Individuals are much softer for hackers targets than governments or major corporations, plus, will technology create a new “species” of super humans by midcentury?
The biotech markets have softened. What’s the state of the forthcoming biotech IPO? Atlas Venture’s Bruce Booth weighs in.
Windgap Medical is moving forward in its development of its EpiPen alternative device with two newly solidified patents.
LifeSci Advisors has formally apologized for hiring cocktail models at this year’s J.P. Morgan healthcare conference, and has committed to “launching a series of concrete initiatives to address these systemic issues.”
JMC Investment took a majority stake in French medical imaging business in Keosys, a participant in the inaugural class.
An alternative way of testing glucose levels without finger pricking is a great solution for young kids and teens.
Also, in the Democratic debate U.S. Sen Bernie Sanders goes after Hillary Clinton over pharma campaign donations influencing her position on drug prices, and a hospital CEO is arrested for prescription drug fraud.
So much news continues to emerge about Theranos. First it was hype, and now it’s notice of decline. So we’ve compiled a handy – and highly comprehensive – timeline (doomsday clock) of the erstwhile unicorn.
We invite you to download eyeforpharma’s freshly released whitepaper, Patient-Centered Culture by Design: Leading the Way. View the full whitepaper plus 13 in-depth interviews with representatives of Janssen, UCB, GSK and Harvard University here.
“It gives clarity, it gives purpose and it gives tenets,” healthcare interoperability consultant Michael Planchart said about his proposed National Health IT Interoperability Manifesto.
The company just raised $3.1 million in seed funding from Giesecke & Devrient, a mobile security supplier to banks, mobile network operators, and original equipment manufacturers.
This week we will take a closer look at how players like Alphabet (Google in general) are really making an impact in healthcare innovation. Does it look promising?
The newly formed Electronic Hand Hygiene Compliance Organization, or EHCO, plans on lobbying CMS, private payers, the Joint Commission and patient safety organizations.
During today’s congressional hearing on drug pricing, Rep. Jason Chaffetz (R-Utah) made his own case […]